Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891836-00-000004
Filing Date
2000-01-05
Accepted
2000-01-05 00:00:00
Documents
1
Group Members
SOLVAY AMERICA, INC.SOLVAY PHARMACEUTICALS, INC.SOLVAY S A /ADR/

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D SC 13D/A 16680
  Complete submission text file 0000891836-00-000004.txt   18565
Mailing Address 5040 LESTER ROAD CINCINNATI OH 45213
Business Address 7155 EAST KEMPER ROAD CINCINNATI OH 45249 5137319900
DURAMED PHARMACEUTICALS INC (Subject) CIK: 0000799903 (see all company filings)

EIN.: 112590026 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-38106 | Film No.: 501795
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUE DU PRINCE ALBERT 33 B-1050 BRUSSELS BELG
Business Address RUE DU PRINCE ALBERT 33 B1050 BRUSSELS BELG
SOLVAY S A /ADR/ (Filed by) CIK: 0000930826 (see all company filings)